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Abstract
Background: Current approaches for AD prediction are based on biomarkers, which are however of restricted availability in
primary care. AD prediction tools for primary care are therefore needed. We present a prediction score based on information
that can be obtained in the primary care setting.
Methodology/Principal Findings: We performed a longitudinal cohort study in 3.055 non-demented individuals above 75
years recruited via primary care chart registries (Study on Aging, Cognition and Dementia, AgeCoDe). After the baseline
investigation we performed three follow-up investigations at 18 months intervals with incident dementia as the primary
outcome. The best set of predictors was extracted from the baseline variables in one randomly selected half of the sample.
This set included age, subjective memory impairment, performance on delayed verbal recall and verbal fluency, on the Mini-
Mental-State-Examination, and on an instrumental activities of daily living scale. These variables were aggregated to a
prediction score, which achieved a prediction accuracy of 0.84 for AD. The score was applied to the second half of the
sample (test cohort). Here, the prediction accuracy was 0.79. With a cut-off of at least 80% sensitivity in the first cohort,
79.6% sensitivity, 66.4% specificity, 14.7% positive predictive value (PPV) and 97.8% negative predictive value of (NPV) for
AD were achieved in the test cohort. At a cut-off for a high risk population (5% of individuals with the highest risk score in
the first cohort) the PPV for AD was 39.1% (52% for any dementia) in the test cohort.
Conclusions: The prediction score has useful prediction accuracy. It can define individuals (1) sensitively for low cost-low
risk interventions, or (2) more specific and with increased PPV for measures of prevention with greater costs or risks. As it is
independent of technical aids, it may be used within large scale prevention programs.
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Introduction
The prevalence of dementia is rapidly growing in high-income
countries and even more so in countries with low and middle
income [1]. As a consequence, the estimated dementia related
costs worldwide increased by 34% between 2005 and 2009 up to
422 billion $ [2]. The most effective approach to slow this steep
rise in burden and costs is prevention of dementia by early
intervention in individuals at increased risk. Recent large efforts in
biomarker development have successfully provided a better
understanding of pre-dementia brain pathology, particularly of
Alzheimer’s disease as the most common cause of dementia [3].
These studies are the basis for innovative diagnostic criteria for
pre-dementia Alzheimer’s Disease [4]. The novel concept of
disease identification prior to the onset of clinical dementia has
been employed in first clinical trials with compounds that aim at
delaying dementia onset [5]. However, current approaches for
identification of subjects at pre-dementia disease stages or at high
risk for dementia all employ biomarkers, mainly from neuroim-
aging or cerebrospinal fluid (CSF). These biomarkers require
highly specialized settings and sophisticated technology to be
reliably assessed.
The vast majority of patients with dementia or pre-dementia
conditions worldwide, however, is only seen and treated by non-
specialized primary care physicians without access to specific
biomarkers. To reach these patients for prevention programs,
detection of subjects at increased risk for dementia in primary care
is needed. In addition to limited access to biomarkers, the primary
care setting is frequently characterized by restricted money and
time budget per patient and by an unselected patient population
with low disease prevalence [6]. Procedures to identify individuals
at risk for dementia in the low prevalence primary care setting with
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are lacking.
Dementia prevention strategies may differ in costs and risks.
Examples of low cost and low risk strategies would be increased
medical attention and counselling on life style. Costs and risks
increase, if specific drugs are considered that either modify risk
factor or directly act upon the diseases process. Selection of
individuals for low risk and low cost interventions should capture
most people with the prospective disease even at the expense of
sampling subjects, who will not get the disease. In this case
prediction should be sensitive, even if high specificity and positive
predictive value (PPV) can not be achieved. If the intervention is of
higher cost or increased risk, selection should be restricted to those,
who will most likely develop the disease at the potential expense of
missing some. In this case specificity and PPV should be higher at
the expense of sensitivity.
A tool that provides a continuous score rather than a fixed
categorical definition can provide different levels of sensitivity,
specificity and PPV by using different cut-offs. If the likelihood for
a future disease increases with a particular score, specificity and
PPV will increase and sensitivity will decrease by raising the cut-off
of the score.
In the German Study on Aging, Cognition and Dementia in
Primary Care Patients (AgeCoDe) we aimed at creating a
quantitative score for primary care physicians to define the risk of
an individual for future dementia based on information that can be
obtain in the primary care setting in acceptable time and at low
costs. We defined two cut-offs. The first was created to sensitively
identify subjects at increased risk for dementia. The second cut-off
aimed at identifying individuals at high risk for dementia with high
specificity and increased PPV. We focused the analyses on
Alzheimer’s Dementia (AD) as the most common type of dementia.
Methods
Ethics statement
The entire study protocol was approved by the local ethical
committees of the Universities of Bonn, Hamburg, Duesseldorf,
Heidelberg/Mannheim, Leipzig and the Technical University of
Munich. Written informed consent was obtained from all
participants of this study.
Participants
The AgeCoDe study is a general practice (GP) registry-based
longitudinal study in elderly individuals that aims at identifying
predictors of cognitive decline and dementia [7,8]. The study
recruited at six German cities (Bonn, Duesseldorf, Hamburg,
Leipzig, Mannheim, Munich). At each site between 19 to 29 GP
were connected to the respective study site (138 GP in total). The
inclusion criteria for participants were age of 75 years and older,
absence of dementia according to GP judgement and at least one
contact with the GP within the last 12 months. Exclusion criteria
were GP consultations by home visits only, living in a nursing
home, severe illness with an anticipated fatal outcome within three
months, insufficient German language abilities, deafness or
blindness and lack of ability to provide informed consent due to
severe mental or sensory impairment or language difficulties.
5102 randomly selected individuals from the GP charts were
successfully contacted. 3327 provided informed consent to the GP
for participation. Main reasons for not consenting were (more than
one answer possible; .10% of cases): no interest in the study
(58%), feeling to weak to participate (13%) and lack of time (12%).
The mean age of participants was 80.1 years (SD=3.6) vs. 80.7
years (SD=3.8) in those who refused participation (p=0.019).
Within the group of the participants 65.5% were women and
34.5% were men; in the group of non-participants 68.9% were
women and 31.1% were men (x
2=6.028, d.f.=1, p=0.014).
The participants were then contacted by the study staff from the
respective study centres. All assessments of participants were
performed by trained interviewers at the subjects’ homes. 85
individuals were excluded after the baseline interview due to the
presence of dementia or age below 75 (these were falsely classified
as 75 or older in the initial chart selection process). For the present
analysis 16 subjects were excluded due to lack of follow-up
information on conversion to dementia and 147 were excluded
due to conversion to non-AD dementia as we focused on AD only
in the present report. These were again included for an
exploratory analysis with all dementia cases as reported below.
The data-base for the present analyses includes 3055 individuals.
Three follow-up waves with 18 months intervals are the basis for
the present analyses. The number of personal interviews was 2634
(86.2%) at follow-up 1, 2338 (76.5%) at follow 2 and 1893 (62.0%)
at follow-up 3. The main reasons for not obtaining a personal
interview were (1) specific refusal regarding a personal visit due to
various reasons (follow-up 1: 63.8%, follow-up 2: 50.5%, follow-up
3: 46%) and (2) death (follow-up 1: 29.7%, follow-up 2: 43.9%,
follow-up 3: 38.4%). Informant-based information on those
participants without personal interview was obtained from
spouses, relatives, caregivers and/or GP on 421 participants at
follow-up 1, on 289 at follow-up 2 and on 413 at follow-up 3. The
combined follow-up rates (personal interview, informant-based
information only) were 100% at follow-up 1, 86.0% at follow-up 2
and 75.5% at follow-up 3. Note that individuals were not followed-
up anymore in the case of incident dementia or informant-based
information only at one follow-up.
The ApoE genotype was determined in 2938 (96.2%) of
participants.
Assessment procedures
The interviews at baseline at all follow-up assessments included
the following procedures.
Subjective memory impairment (SMI) was assessed by the
questions: ‘‘Do you feel like your memory is becoming worse? ’’
Possible answers were: ‘‘no’’; ‘‘yes, but this does not worry me’’
and ‘‘yes, this worries me’’.
Neuropsychological assessment included the Structured Inter-
view for Diagnosis of Dementia of Alzheimer type, Multi-infarct
Dementia and Dementia of other Aetiology according to DSM-IV
and ICD-10 (SIDAM) [9]. The SIDAM is specifically designed to
diagnose dementia according to the named criteria. It contains (1)
a neuropsychological test battery, (2) a 14-item scale for the
assessment of activities of daily living (SIDAM-ADL-Scale) and (3)
the Hashinski Rosen-Scale [10]. The neuropsychological battery is
comprised of 55 items (SIDAM cognitive score, SISCO), including
the Mini Mental State Examination (MMSE) [11]. German age-
and education-specific norms for the SISCO are published [12].
In addition to the SISCO, the semantic verbal fluency test
(naming of animals in 1minute) and the verbal memory test (10-
item word list, 3 presentations, delayed recall after 10 minutes) of
the neuropsychological battery of the CERAD (Consortium to
Establish a Registry for Alzheimer’s Disease) were administered
[13].
ADL were assessed with the SIDAM ADL scale for definition of
dementia (see below). In addition instrumental ADL only were
assessed with the Instrumental ADL (IADL) scale [14].
Depressive symptoms were assessed by the 15-item version of
the Geriatric Depression Scale (GDS) [15]. Education was
classified by the Comparative Analysis of Social Mobility in
Dementia Prediction in Primary Care
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middle and high [16].
The dementia risk factors smoking habits (yes/no) [17] and
family history of dementia (yes/no) [18] as well as living status
(alone/not alone) were additionally assessed with individual
questions. Medical history was obtained from the GPs in all cases.
For those subjects, who could not be interviewed in person at
follow-up the Global Deterioration Scale [19]and the subscales
‘‘Changes in Performance of Everyday Activities’’ and ‘‘Changes
in Habits’’ of the Blessed Dementia Scale [20] were completed by
the interviewer with an informant (spouse, relative, caregiver)
and/or with the GP.
Definition of dementia
Dementia was diagnosed in a consensus conference with the
interviewer and an experienced geriatrician or geriatric psychia-
trist according to the criteria set of DSM-IV, which is
implemented as a diagnostic algorithm in the SIDAM. The
algorithm includes cognitive impairment as defined by the SISCO
and impairment of activities of daily living as defined by a score of
at least two points on the SIDAM-ADL scale. The etiological
diagnosis of dementia in AD was established according the
NINCDS-ADRDA criteria for probable AD [21]. Vascular
dementia diagnosis was guided by the NINDS-AIREN criteria
[22], i.e. in case of evidence for cerebrovascular events (Hashinski-
Rosen Scale, medical history) and a temporal relationship between
the cerebrovascular event and the occurrence of cognitive decline.
Mixed dementia was diagnosed in cases of cerebrovascular events
without temporal relationship to cognitive decline. For all analyses,
mixed dementia and dementia in AD were combined. Dementia
diagnosis in subjects who were not personally interviewed was
based on the Global Deterioration Scale and the Blessed Dementia
Rating subscales. A score of .=4 on the Global Deterioration
Scale was used as the criterion for the dementia diagnosis. In these
cases an etiological diagnosis was established, if the information
provided was sufficient to judge aetiology according to the criteria
named above.
Statistical analyses
Age, sex, education, the presence of SMI with or without
worries, the IADL scale score, the living status, the score on the
GDS score, smoking habits (yes/no), family history of dementia in
first degree relatives (positive/negative), the verbal fluency score,
the verbal delayed recall score and the MMSE score were included
as predictor candidates (table 1). With the aim to create a score,
variables that are continuous or have multiple categories ware
categorized. Age was divided at the mean of the cohort into ,80
years and .=80 years of age. The IADL scale was categorized as
impaired or not impaired according to the convention of the scale
(impairment: ,8 points for women, ,5 points for men) [14]. The
Geriatric Depression Scale was dichotomized according to the
convention of the scale into ,6 points (no evidence for depression)
and .=6 points (evidence for depression). The verbal fluency
performance was dichotomized into ,18 words and .=18 words
in one minute. The delayed recall of the 10-item word list, as the
presumably most sensitive measure of prodromal AD, was divided
into three categories (0–4 words, 5–6 words, 7–10 words). The
MMSE was categorized into ,27 points and .=27 points. The
bivariate association of each variable with AD at any follow-up
was examined applying x
2 test or Linear Trend test for variables
with ordered categories, respectively (table 1).
The cohort was then split randomly into two samples of equal
size using the first as the sample to develop the risk score, and the
second as the test sample to assess the predictive accuracy of the
score [23,24].
Multivariate Cox proportional hazard regression was performed
to assess the influence of the candidate predictors on the time to
onset of AD in the first cohort. A backward stepwise selection of
variables based on the Schwarz Bayesian information criterion
(BIC) was applied to reduce overfitting [25–28]. The BIC
penalizes the log likelihood of a model (a measure of its fit) by a
factor related to the number of predictor variables in the model (a
measure of its complexity) and the number of cases [29]. A
reduction of BIC indicates model improvement.
For the calculation of a risk index all predictors of the final
model were used. The risk index was calculated as the sum of the
respective b coefficients of each factor. To assess the discrimina-
tion of the risk index between individuals with and without
incidental AD the receiver operating characteristics (ROC), the
area under the ROC curve (AUC) and its 95% confidence interval
(CI) were calculated. The final model was recalculated with the
inclusion of the ApoE4 carrier status to assess the additional effect
of ApoE in prediction of AD in this sample.
To create the final scoring system the b coefficients were
standardized to an integer score point. The risk score is the sum of
these score points.
We defined two cut-offs of the score for different definitions of
at-risk groups. The first cut-off should sensitively identify
individuals at risk with limited specificity and PPV as a trade-off.
For this purpose the cut-off was defined to achieve at least a
sensitivity of 80% in the first cohort. The second cut-off should
identify a high-risk group with high specificity and increased PPV.
This was achieved by defining the upper decile (10%) of the risk
score as the risk group only. The cumulative hazard rates for the
respective risk groups were calculated using the Kaplan-Meier
method [30]. Exploratively, we calculated the PPV for the top 5%
of the risk score for AD and for any dementia by including the
additional cases with any dementia at follow-up.
For validation, the predictive accuracy for both the risk index
and the simplified risk score were assessed in the test sample. In
addition, sensitivity, specificity, PPV and NPV for the cut-offs were
determined in the test sample and positive and negative likelihood
ratios (LR
+,L R
2) for both cohorts.
Results
The baseline characteristics of the participants are listed in
table 1. From the 3055 participants, 193 (6.32%) developed AD
during follow-up. The mean follow-up time per individual was
3.81 years (maximum: 6.14 years).
Selection of predictive factors
All 12 factors were included in the multivariate Cox
proportional hazard model based and applied to the search
sample. The stepwise selection of variables based on the BIC
revealed improvement of the model after removing the GDS score
(24.42), smoking status (24.40), family history of dementia
(24.30), living status (24.22), education (27.02) and sex
(21.27). Removing IADL impairment worsened the model as
shown by in increased BIC (+1.80). The order of removing
variables was determined by their Wald x
2. The final model
included the predictors age, presence of SMI with and without
worry, IADL score, verbal fluency score, delayed recall score and
MMSE score.
The estimated b coefficients, the Hazard Risk ratios and the
95% confidence intervals are shown in table 2.
Dementia Prediction in Primary Care
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the risk index was 0.84 (95% CI: 0.80–0.88) in the first cohort.
In a second analysis in the first cohort, the Apoe4 status
(carrier/non-carrier) was included as a predictor. The estimated b
coefficients, the Hazard Risk ratios and the 95% confidence
intervals were similar as in the model without ApoE4 carrier status
without any change in significance (data not shown). The added
hazard ratio of the ApoE4 status itself was not significant. The
AUC of the corresponding risk index of the model with ApoE4
carrier status was 0.85 (95% CI: 0.80–0.89).
Risk score for AD
From the final model a simplified risk score was derived by
multiplying the b coefficients with 10/3. The multiplication with 10/
3 was chosen because most of the b coefficients were close to divisible
by 3, thus rounding errors were kept small. Scoring points are
presented in table 2. For an individual, the risk score is the sum of the
score points of each predictor (maximum 21 points). The AUC for
the corresponding ROC curve was 0.84 (95% CI: 0.80–0.88). There
was no significant difference between the AUC of original risk index
and the simplified risk score (p=0.063, see figure 1).
Validation in the test cohort
Applying the risk score of the model to the test sample revealed
an AUC of 0.79 (95% CI: 0.74–0.84), which was not significantly
different from the AUC of the first sample (p=0.13). Both curves
are depicted in figure 2.
Prediction of AD
The risk score cut-off had to be positioned at .=9 points to
achieve the requirement of at least 80% sensitivity in the first
cohort. To define the high-risk group, the risk score was
dichotomized into the upper decile and the rest of participants
in the first cohort (.=15 points).
At a cut-off of .=9 points the score achieved a sensitivity of
85.5%, a specificity of 63.8%, a PPV of 12.0% and a NPV of
98.7% for the prediction of AD in the first cohort (LR
+=2.36,
LR
2=0.23). In the test cohort a sensitivity of 79.6%, a specificity
of 66.4% and PPV of 14.7% and a NPV of 97.8% was achieved
(LR
+=2.37, LR
2=0.31).
The decile division reached a sensitivity of 28.9%, a specificity
of 92.8%, a PPV of 28.9% and a NPV of 95.5% for the prediction
of AD in the first cohort (LR
+=5.53, LR
2=0.65). In the test
Table 1. Description of study sample.
total cohort
(n=3055)*
first sample (randomly
selected from total cohort,
n=1526)
test sample (randomly selected
from total cohort, n=1529)
No AD at
follow-up
AD at follow-
up p#
No AD at
follow-up
AD at follow-
up
No AD at
follow-up AD at follow-up
(n=2862) (n=193) (n=1438) (n=88) (n=1424) (n=105)
Age $ 80 years 1274 (44.5%) 137 (71.0%) ,0.001 628 (43.7%) 64 (72.7%) 646 (45.4%) 73 (69.5%)
Sex Male
Female
1000 (34.9%)
1862 (65.1%)
50 (25.9%)
143 (74.1%)
0.011 507 (35.3%)
931 (64.7%)
17 (19.3%)
71 (80.7%)
493 (34.6%)
931 (65.4%)
33 (31.4%)
72 (68.6%)
SMI
1 no 1248 (43.6) 43 (22.3%) 603 (41.9%) 18 (20.5%) 645 (45.3%) 25 (23.8%)
yes, without worry 1191 (41.6) 86 (44.6%) 617 (42.9%) 38 (43.2%) 574 (40.3%) 48 (45.7%)
yes, with worry 423 (14.8) 64 (33.2%) ,0.001 218 (15.2%) 32 (36.4%) 205 (14.4%) 32 (30.5%)
Verbal fluency ,18 words 994 (34.7%) 129 (67.2%) ,0.001 492 (34.2%) 60 (69.0%) 502 (35.3%) 69 (65.7%)
Delayed recall 7–10 words 1015 (35.7%) 13 (7.0%) 501 (34.9%) 7 (8.4%) 514 (36.4%) 6 (5.8%)
5–6 words 966 (33.9%) 47 (25.3%) 506 (35.3%) 21 (25.3%) 460 (32.6%) 26 (25.2%)
0–4 words 866 (30.4%) 126 (67.7%) ,0.001 427 (29.8%) 55 (66.3%) 439 (31.1%) 71 (68.9%)
MMSE
2 ,27 points 663 (23.2%) 107 (55.4%) ,0.001 344 (23.9%) 56 (63.6%) 319 (22.4%) 51 (48.6%)
GDS
3 $6 points 238 (8.3%) 29 (15.1%) 0.001 121 (8.4%) 14 (15.9%) 117 (8.2%) 15 (14.4%)
IADL
4 impaired 226 (7.9%) 37 (19.2%) ,0.001 110 (7.6%) 21 (23.9%) 116 (8.1%) 16 (15.2%)
Education
5 low 1758 (61.4) 128 (66.3%) 917 (63.8%) 59 (67.0%) 841 (59.1%) 69 (65.7%)
middle 794 (27.7%) 46 (23.8%) 368 (25.6%) 22 (25.0%) 426 (29.9%) 24 (22.9%)
high 310 (10.8%) 19 (9.8%) 0.246 153 (10.6%) 7 (8.0%) 157 (11.0%) 12 (11.4%)
Living status alone 1462 (51.1%) 104 (53.9%) 0.451 737 (51.3%) 52 (59.1%) 725 (50.9%) 52 (49.5%)
Smoking yes 218 (7.6%) 11 (5.7%) 0.327 118 (8.2%) 6 (6.8%) 100 (7.0%) 5 (4.8%)
Family history Positive for
dementia
544 (19.0%) 40 (20.7%) 0.557 274 (19.1%) 16 (18.2%) 270 (19.0%) 24 (22.9%)
ApoE genotype e4 carrier 538 (19.5%) 68 (37.0%) ,0.001 294 (21.4%) 28 (33.3%) 244 (17.7%) 40 (40.0%)
* All variables except ApoE genotype: Number of missing values: 0–22; ApoE genotype: Number of missing values: 117.
#x
2 test or Linear Trend test for group comparison.
1subjective memory impairment,
2Mini-Mental-Status-Examination,
3Geriatric Depression Scale,
4Instrumental Activities of Daily Living Scale,
5according to the Comparative Analysis of Social Mobility in Industrial Nations (CASMIN) classification system.
doi:10.1371/journal.pone.0016852.t001
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of 26.9% and a NPV of 96.8% was achieved (LR
+=6.35,
LR
2=0.57).
The rates of progression to dementia for both cut-offs are listed
table 3. Figures 3 and 4 display the respective survival curves.
Discussion
The aim of this study was the creation of a score for the
identification of individuals at risk for AD in elderly primary care
patients. All variables of this score should be easily obtainable in
the primary care setting in acceptable time and at low cost. The
interpretation should be straight forward based on cut-offs. We
identified significant predictors for AD out of a larger set of
variables, created the score in a randomly selected first cohort and
validated the score in second half of the sample (test cohort).
The prediction accuracy (AUC) of the score was 0.84 in the first
cohort and 0.79 in the test cohort. We defined two cut-offs, one
with high sensitivity of .80% in the first cohort and limited
specificity and PPV and one with high specificity and increased
PPV. The first cut-off (.=9 points) achieved a sensitivity of
79.6%, a PPV of 14.7% and a NPV of 97.8% in the test cohort.
This cut-off is sensitive and potentially over inclusive. It can be
applied, if the consequence of being at risk according to this cut-off
is of low risk and low cost for the individual. Subjects at risk
according to this definition may receive intensified counselling
regarding modifiable risk factors related to lifestyle and may
receive increased clinical attention to identify first signs of
dementia.
The second-cut off (./=15) points reached a specificity of
92.6%, a PPV of 26.9% and a NPV of 96.8% in the test cohort.
Those individuals scoring above this cut-off are at high risk with
Table 2. Cox regression models for Alzheimer dementia risk (first cohort, n=1526).
full model final model
b coefficient p HR
1 95% CI b coefficient p HR 95% CI Score
Age 75–79 years 0 1 0 1 0
$80 years 0.959 0.0002 2.610 1.566–4.349 1.015 ,0.0001 2.758 1.671–4.555 3
Sex male 0 1
female 0.605 0.0598 1.831 0.975–3.437
SMI
2 no 0 1 0 1 0
yes, without
worry
0.622 0.0358 1.863 1.042–3.331 0.630 0.0331 1.876 1.052–3.347 2
yes, with worry 1.256 ,0.0001 3.512 1.898–6.499 1.299 ,0.0001 3.662 2.001–6.702 4
Verbal fluency $18 0 1 0 1 0
,18 1.057 ,0.0001 2.877 1.746–4.740 1.084 ,0.0001 2.956 1.809–4.830 4
Delayed recall 7–10 0 1 0 1 0
5–6 0.641 0.1516 1.898 0.791–4.555 0.598 0.1780 1.818 0.762–4.338 2
0–4 1.415 0.0009 4.117 1.791–9.465 1.312 0.0018 3.712 1.630–8.452 4
MMSE
3 $27 0 1 0 1 0
,27 1.107 ,0.0001 3.024 1.877–4.873 1.097 ,0.0001 2.996 1.872–4.795 4
GDS
4 ,60 1
$6 0.018 0.9550 1.018 0.540–1.922
IADL
5 unimpaired 0 1 0 1 0
impaired 0.581 0.0444 1.789 1.015–3.153 0.707 0.0079 2.028 1.204–3.415 2
Education
6 high 0 1
middle 0.270 0.3247 1.311 0.765–2.245
low 0.489 0.2380 1.630 0.724–3.671
Living status not alone 0 1
alone 20.118 0.6429 0.889 0.540–1.462
Smoking no 0 1
yes 20.053 0.9060 0.948 0.394–2.282
Family history Negative for
dementia
01
Positive for
dementia
20.099 0.7320 0.905 0.513–1.599
1Hazard Ratio,
2subjective memory impairment,
3Mini-Mental-Status-Examination,
4Geriatric Depression Scale,
5Instrumental Activities of Daily Living Scale,
6according to the Comparative Analysis of Social Mobility in Industrial Nations (CASMIN) classification system.
doi:10.1371/journal.pone.0016852.t002
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period. Individuals in the high risk group according to this
definition could be subject to intensified pharmacological and non-
pharmacological prevention programs that might be developed in
the future [4].
Both cut-offs achieved NPV above 95% indicating that low
scoring on the risk score is associated with very low risk for AD at
follow-up.
It needs to be stressed at this point that in low prevalence
populations as in primary care the PPV tends to be low and the
NPV tends to be high compared with high prevalence populations
that characterize specialized settings. This is also the case for
several other medical conditions that occur in primary care, such
as depression [31]. This effect is caused by the unselected nature of
low prevalence populations, which includes individuals, who fulfil
at-risk criteria due to any reasons and not only due to the
prodromal disease of interest (AD in the case of this study). These
individuals are a priori excluded from the highly selected
population of specialized settings. As such, the measures reported
here cannot be directly compared to high PPV obtained in
biomarker studies in high prevalence cohorts from specialist
settings.
Other prediction scores for dementia have been published. In
one study a risk score for dementia prediction over the course of
20 years was generated from a cohort with an age at baseline of 50
years on average. The authors identified age, education, sex,
systolic blood pressure, body mass index, total cholesterol, physical
activity and the ApoE4 status as components of the score. They
reported a prediction accuracy (AUC) of 0.77 with a PPV of 9%
and a NVP of 98% [32]. This score highlights the relevance of
mid-life risk factors for dementia. However, due to the long
prediction period of 20 years and midlife age at baseline, it is
clinically not useful for dementia risk assessment in elderly primary
care patients.
Figure 1. Receiver operating characteristics (ROC) of the risk index and the simplified risk score in the first cohort.
doi:10.1371/journal.pone.0016852.g001
Figure 2. Receiver operating characteristics (ROC) of the risk score in the first cohort and in the test cohort.
doi:10.1371/journal.pone.0016852.g002
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population-based cohort with a mean baseline age of 76 years and an
observation period of 6 years. The score included the predictors age,
cognitive test performance, body mass index, ApoE4 status, white
matter lesions on MRI or ventricular enlargement, internal carotid
thickening, history of by-pass surgery, slow physical performance and
lack of alcohol consumption [33]. The accuracy of prediction (AUC)
was 0.81. The PPV was 57% for individuals scoring in the top 5% of
the prediction score for any dementia. In our analysis, we defined the
top scoring 10% on the risk score as the high-risk group. Narrowing
the high-risk definition to 5% in our data would have increased the
PPV to 39.1% for AD. Employing any dementia exploratively as an
outcome, the PPV was 52.0% for the top scoring 5% on the risk score
in the test cohort of our study. However, a group size of only 5%
might be of limited utility in clinical practice for the definition of
individuals that may receive specific programs or treatments. Any
dementia as the prediction target instead of only AD is unspecific and
limits the application of the risk score, if actions specifically tailored
for pre-dementia Alzheimer’s disease are considered.
Importantly, the AUC of our data and those of the other
prediction scores are in a similar range indicating similar
performance. In contrary to the score reported by Barnes et al.,
our score did not include components derived from technical
investigations such as MRI or ultrasound [33].
However, we included clinical information that was not
included in the other scores. In our data, SMI significantly
predicted AD. This is in agreement with the majority of
longitudinal studies that found an association of SMI with future
cognitive decline and dementia [34,35]. Importantly, character-
istics of SMI that induce worry in individuals are associated with
greater risk than SMI that does not cause worry. It needs to be
stressed, however, that not all individuals report SMI in the
prodromal phase of AD [e.g. 36].
In our data impairment in IADL contributes to the prediction
score. Note, that patients with clearly impaired ADL fulfilling
dementia criteria were excluded at baseline. Impairment in IADL
has been identified as an important predictor of dementia in
subjects with mild cognitive impairment (MCI) in other epidemi-
Table 3. Rate of progression to AD by risk score.
Training cohort Test cohort
Baseline risk
score
Number of AD cases
at follow-up
Mean time to
incident AD 95% CI
Number of AD cases
at follow-up
Mean time to
incident AD 95% CI
Group definition 1
a
0–8 12 (1.3%) 5.9 5.9–5.9 21 (2.2%) 6.1 6.1–6.1
$9 71 (12.0%) 5.4 5.3–5.5 82 (14.7%) 4.9 4.8–4.9
Total 83 (5.5%) 5.8 5.7–5.8 103 (6.8%) 5.9 5.8–5.9
Group definition 2
b
0–14 44 (3.2%) 5.9 5.8–5.9 62 (4.5%) 5.9 5.9–6.0
$15 39 (26.9%) 4.3 4.1–4.6 41 (28.9%) 4.3 3.9–4.6
Total 83 (5.5%) 5.8 5.7–5.8 103 (6.8%) 5.9 5.8–5.9
aThe cut-off of the risk score was defined as to achieve a sensitivity of at least 80% in the first cohort.
bThe cut-off was defined to separate the 10% individuals with the highest risk score from the rest in the first cohort and to define them as a high risk group.
AD=Alzheimer’s dementia.
doi:10.1371/journal.pone.0016852.t003
Figure 3. AD-free survival in the first cohort and the test cohort by the criterion of at least 80% sensitivity in the first cohort (0–9
and .=10 points).
doi:10.1371/journal.pone.0016852.g003
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highlights the relevance of functional impairment in addition to
purely cognitive impairment in the prediction of AD.
In our data delayed episodic memory performance, as measured
by word list recall, contributed to the risk score. This is in
agreement with current concepts of AD proposing episodic
memory impairment as the cardinal feature of cognitive decline
in early AD [4]. Verbal fluency performance and the MMSE score
as a measure of global cognitive function also contributed to the
prediction score. This is in agreement with studies showing that
MCI subjects with impairment in more cognitive domains than
just episodic memory (multi domain amnestic MCI) are at
particular high risk for dementia [39,40]. In other longitudinal
cohorts either specific memory tests or global tests of cognition
alone achieved reasonable dementia prediction accuracy
[41,42,43]. Direct comparison of these studies with our data is
limited by differences in setting, subjects, instruments and other
factors. In our model, however, we found improvement of
prediction by including those clinical variables listed above in
addition to cognitive tests.
In this study risk modifying factors for AD such as sex, family
history of dementia, depressive symptoms, education and smoking
[44,45] did not contribute independently to the prediction of AD.
This suggest that prodromal symptoms of dementia such as
subjective decline, cognitive impairment and mild impairment of
function contribute to prediction, whereas the independent effects
of pure risk factors are minor in predicting dementia in elderly
subjects over a limited number of years.
In agreement, the ApoE4 status also did not contribute
independently to risk prediction of AD and did not increase the
performance of the risk index. This suggests that determination of
the ApoE genotype in not necessarily required for risk assessment
in the primary care patient population above 75 years of age.
This study has limitations. The inclusion age was 75–90 years in
order to define risk for dementia in high age individuals.
Consequently, the prediction score cannot be directly applied to
younger age groups.
The observational period per participants was 3.8 years on
average (maximum 6.14 years). Thus, our data reflect prediction
in a rather short time frame. A longer follow-up frame with more
incidental AD case would have provided greater accuracy of
prediction estimates.
The diagnosis of AD was based on interview and test material.
It did not include brain imaging. However, it is unlikely that the
increased validity of the etiological diagnosis achieved by the
inclusion of brain imaging would weaken the performance of the
risk score as the score empirically reflects the conceptual
components of early symptom manifestation of AD. It can be
speculated that the prediction of AD would have been even more
accurate, if brain imaging would have been included to establish
the diagnosis.
We restricted the primary analyses to AD as the most common
type of dementia. The strategy was chosen, because AD is
conceptually well defined and most knowledge on prevention of
dementia refers specifically to AD.
In our study, we derived the score from one half of the cohort
and tested it in the other half. However, the performance of the
score needs to be replicated in independent samples from different
language and socioeconomic backgrounds to test its validity for
widespread use.
In conclusion, we identified a set of predictors and we created a
risk score for AD in elderly primary care patients. The relevant
components of the score are (1) the report on memory impairment
by the individual on active inquiry (SMI) plus the quality of this
subjective impairment (worrisome/not worrisome), (2) perfor-
mance on a global cognitive test (MMSE), and on a more specific
tests of episodic verbal memory (10-item word list learning) and of
verbal fluency (e.g. naming of animals in one minute), (3)
performance of IADL, and (4) age. All required information is
obtainable in daily practice without any major technical effort. In
contrast to a categorical risk definition, such as MCI, the score can
serve different purposes by varying the cut-off. The score can
guide primary care physicians’ decision in individual patients on
actions such as increased clinical attention, counselling as well as
initiation of measures for prevention and for early diagnosis.
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